CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,285,604
- in 7 filings, $33.3M under 10b5-1 plans
Net −$33,285,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-28 | BAKER BROS. ADVISORS LP Director | Grant or award | +543 | 33,447,981 | ||
| 2024-03-25 | Trotta Matteo EVP, GM, Dermatology US | Grant or award | +7,828 | 7,828 | ||
| 2024-03-25 | Trotta Matteo EVP, GM, Dermatology US | Grant or award · Employee Stock Option (right to buy) | +21,868 | 21,868 | ||
| 2024-02-14 | Hoppenot Herve Chairman / CEO | Grant or award | +41,577 | 502,333 | ||
| 2024-02-14 | SWAIN PAULA J EVP, Human Resources | Grant or award | +7,377 | 84,907 | ||
| 2024-02-14 | Stein Steven H EVP & Chief Medical Officer | Grant or award | +7,377 | 97,595 | ||
| 2024-02-14 | Stamoulis Christiana EVP & Chief Financial Officer | Grant or award | +7,377 | 89,983 | ||
| 2024-02-14 | Iyengar Vijay K EVP, GMAPPS | Grant or award | +7,377 | 50,789 | ||
| 2024-02-14 | Flannelly Barry P EVP & General Manager US | Grant or award | +7,377 | 85,080 | ||
| 2024-02-12 | Stamoulis Christiana EVP & Chief Financial Officer | Shares withheld for taxes | −387 | $57.84 | $22K | 82,606 |
| 2024-01-22 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −108 | $61.50 | $7K | 72,300 |
| 2024-01-22 | Dickinson Jonathan Elliott EVP, General Manager, Europe | Shares withheld for taxes | −108 | $61.50 | $7K | 44,380 |
| 2024-01-19 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −122 | $61.49 | $8K | 72,408 |
| 2024-01-19 | Dickinson Jonathan Elliott EVP, General Manager, Europe | Shares withheld for taxes | −122 | $61.49 | $8K | 44,488 |
| 2024-01-18 | CAGNONI PABLO J President, R&D | Grant or award · Employee Stock Option (right to buy) | +21,843 | 21,843 | ||
| 2024-01-18 | Morrissey Michael James EVP, Head of Tech. Operations | Grant or award | +11,359 | $61.18 | $695K | 72,530 |
| 2024-01-18 | Dickinson Jonathan Elliott EVP, General Manager, Europe | Grant or award | +8,114 | $61.18 | $496K | 44,610 |
| 2024-01-18 | SWAIN PAULA J EVP, Human Resources | Grant or award · Employee Stock Option (right to buy) | +16,018 | 16,018 | ||
| 2024-01-18 | Stein Steven H EVP & Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +30,580 | 30,580 | ||
| 2024-01-18 | Iyengar Vijay K EVP, GMAPPS | Grant or award · Employee Stock Option (right to buy) | +16,018 | 16,018 |
Page 30 of 35 · 681 trades